Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 136.38 USD -0.99% Market Closed
Market Cap: 8.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Intrinsic Value

The intrinsic value of one ASND stock under the Base Case scenario is 168.55 USD. Compared to the current market price of 136.38 USD, Ascendis Pharma A/S is Undervalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ASND Intrinsic Value
168.55 USD
Undervaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ascendis Pharma A/S

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ASND
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ASND cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ASND?
Bearish
Neutral
Bullish

Fundamental Analysis

136.38 USD
-0.99%
-0.99%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Ascendis Pharma A/S
DK
Biotechnology
Market Cap
8.3B USD
IPO
Jan 28, 2015
Employees
639
Denmark
Market Cap
8.3B USD
Industry
Biotechnology
IPO
Jan 28, 2015
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Ascendis Pharma A/S

Provide an overview of the primary business activities
of Ascendis Pharma A/S.

What unique competitive advantages
does Ascendis Pharma A/S hold over its rivals?

What risks and challenges
does Ascendis Pharma A/S face in the near future?

Summarize the latest earnings call
of Ascendis Pharma A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ascendis Pharma A/S.

Provide P/S
for Ascendis Pharma A/S.

Provide P/E
for Ascendis Pharma A/S.

Provide P/OCF
for Ascendis Pharma A/S.

Provide P/FCFE
for Ascendis Pharma A/S.

Provide P/B
for Ascendis Pharma A/S.

Provide EV/S
for Ascendis Pharma A/S.

Provide EV/GP
for Ascendis Pharma A/S.

Provide EV/EBITDA
for Ascendis Pharma A/S.

Provide EV/EBIT
for Ascendis Pharma A/S.

Provide EV/OCF
for Ascendis Pharma A/S.

Provide EV/FCFF
for Ascendis Pharma A/S.

Provide EV/IC
for Ascendis Pharma A/S.

Show me price targets
for Ascendis Pharma A/S made by professional analysts.

What are the Revenue projections
for Ascendis Pharma A/S?

How accurate were the past Revenue estimates
for Ascendis Pharma A/S?

What are the Net Income projections
for Ascendis Pharma A/S?

How accurate were the past Net Income estimates
for Ascendis Pharma A/S?

What are the EPS projections
for Ascendis Pharma A/S?

How accurate were the past EPS estimates
for Ascendis Pharma A/S?

What are the EBIT projections
for Ascendis Pharma A/S?

How accurate were the past EBIT estimates
for Ascendis Pharma A/S?

Compare the revenue forecasts
for Ascendis Pharma A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ascendis Pharma A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ascendis Pharma A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ascendis Pharma A/S compared to its peers.

Compare the P/E ratios
of Ascendis Pharma A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Ascendis Pharma A/S with its peers.

Analyze the financial leverage
of Ascendis Pharma A/S compared to its main competitors.

Show all profitability ratios
for Ascendis Pharma A/S.

Provide ROE
for Ascendis Pharma A/S.

Provide ROA
for Ascendis Pharma A/S.

Provide ROIC
for Ascendis Pharma A/S.

Provide ROCE
for Ascendis Pharma A/S.

Provide Gross Margin
for Ascendis Pharma A/S.

Provide Operating Margin
for Ascendis Pharma A/S.

Provide Net Margin
for Ascendis Pharma A/S.

Provide FCF Margin
for Ascendis Pharma A/S.

Show all solvency ratios
for Ascendis Pharma A/S.

Provide D/E Ratio
for Ascendis Pharma A/S.

Provide D/A Ratio
for Ascendis Pharma A/S.

Provide Interest Coverage Ratio
for Ascendis Pharma A/S.

Provide Altman Z-Score Ratio
for Ascendis Pharma A/S.

Provide Quick Ratio
for Ascendis Pharma A/S.

Provide Current Ratio
for Ascendis Pharma A/S.

Provide Cash Ratio
for Ascendis Pharma A/S.

What is the historical Revenue growth
over the last 5 years for Ascendis Pharma A/S?

What is the historical Net Income growth
over the last 5 years for Ascendis Pharma A/S?

What is the current Free Cash Flow
of Ascendis Pharma A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ascendis Pharma A/S.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ascendis Pharma A/S

Current Assets 973.7m
Cash & Short-Term Investments 625.5m
Receivables 50.4m
Other Current Assets 297.9m
Non-Current Assets 120m
Long-Term Investments 16.2m
PP&E 97.5m
Intangibles 4.1m
Other Non-Current Assets 2.2m
Current Liabilities 838.5m
Accounts Payable 75.3m
Short-Term Debt 422.1m
Other Current Liabilities 341.1m
Non-Current Liabilities 352.6m
Long-Term Debt 338.9m
Other Non-Current Liabilities 13.7m
Efficiency

Earnings Waterfall
Ascendis Pharma A/S

Revenue
327.4m EUR
Cost of Revenue
-49.7m EUR
Gross Profit
277.7m EUR
Operating Expenses
-593.5m EUR
Operating Income
-315.8m EUR
Other Expenses
-110.7m EUR
Net Income
-426.5m EUR

Free Cash Flow Analysis
Ascendis Pharma A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ASND Profitability Score
Profitability Due Diligence

Ascendis Pharma A/S's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional Revenue Growth Forecast
55/100
Profitability
Score

Ascendis Pharma A/S's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

ASND Solvency Score
Solvency Due Diligence

Ascendis Pharma A/S's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Short-Term Solvency
Long-Term Solvency
38/100
Solvency
Score

Ascendis Pharma A/S's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ASND Price Targets Summary
Ascendis Pharma A/S

Wall Street analysts forecast ASND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASND is 196.93 USD with a low forecast of 154.53 USD and a high forecast of 303.45 USD.

Lowest
Price Target
154.53 USD
13% Upside
Average
Price Target
196.93 USD
44% Upside
Highest
Price Target
303.45 USD
123% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ASND?

Click here to dive deeper.

Dividends

Ascendis Pharma A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for ASND is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one ASND stock?

The intrinsic value of one ASND stock under the Base Case scenario is 168.55 USD.

Is ASND stock undervalued or overvalued?

Compared to the current market price of 136.38 USD, Ascendis Pharma A/S is Undervalued by 19%.

Back to Top